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Abstract
Streptococcus pneumonia (the pneumococcus) is the leading vaccine preventable cause
of serious infections in infants under 5 years of age. The major correlate of protection for
pneumococcal infections is serotype-specific IgG antibody. More recently, antibody-
independent mechanisms of protection have also been identified. Preclinical studies have
found that IL-17 secreting CD4+ Th17 cells in reducing pneumococcal colonisation. This
study assessed IL-17A levels in children from Fiji with high and low pneumococcal carriage
density, as measured by quantitative real-time PCR (qPCR). We studied Th17 responses in
54 children who were designated as high density carriers (N=27, >8.21x105 CFU/ml) or low
density carriers (N=27, <1.67x105 CFU/ml). Blood samples were collected, and isolated pe-
ripheral blood mononuclear cells (PBMCs) were stimulated for 6 days. Supernatants were
harvested for cytokine analysis by multiplex bead array and/or ELISA. Th17 cytokines as-
sayed included IL-17A, IL-21, IL-22 as well as TNF-α, IL-10, TGF-β, IL-6, IL-23 and IFNγ.
Cytokine levels were significantly lower in children with high density pneumococcal carriage
compared with children with low density carriage for IL-17A (p=0.002) and IL-23 (p=0.04).
There was a trend towards significance for IL-22 (p=0.057) while no difference was ob-
served for the other cytokines. These data provide further support for the role of Th17-
mediated protection in humans and suggest that these cytokines may be important in the
defence against pneumococcal carriage.
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Introduction
The bacterium Streptococcus pneumoniae is the most common bacterial respiratory pathogen
and causes significant morbidity and mortality in children under the age of five worldwide [1].
An estimated 700,000–1 million deaths per year are attributable to the pneumococcus, most of
which occur in developing countries [2]. The primary virulence factor of Streptococcus pneu-
moniae is the polysaccharide capsule, which is the basis of current pneumococcal vaccines [3].
There are 94 pneumococcal serotypes, which express structurally and antigenically different
capsular polysaccharides [4]. Pneumococci colonise the nasopharynx and this colonisation can
lead to the development of diseases such as meningitis, bacteraemia, sepsis and pneumonia [5].
Protection against pneumococcal infections by current pneumococcal conjugate vaccines
(PCVs) is dependent on the production of serotype-specific IgG antibody, which is the major
correlate of protection. Although PCVs are highly effective against invasive pneumococcal dis-
ease (IPD), they appear to be less effective against mucosal disease and carriage. While protec-
tion against IPD is mediated by serotype-specific IgG, the mechanisms of protection against
colonisation and mucosal disease are less understood. Recent studies have found that there are
factors other than antibodies (capsular and non-capsular) may play a role in protection against
pneumococcal colonisation and disease.
Protection against pneumococcal colonisation is mediated by the IL-17A producing Th17
cells [6]. IL-17A signals the recruitment and activation of neutrophils and macrophages to the
nasopharynx, leading to the clearance of pneumococci [7]. Many studies have reported a role
for CD4+ Th17 cells in reducing pneumococcal colonisation in mouse models. Naive mice
lacking CD4+ Th17 cells were not protected against pneumococcal carriage, however immuni-
ty was restored with the subsequent transfer of IL-17 secreting CD4+ T cells [8]. In this study,
Lu et al. further demonstrated the critical role of IL-17A, as IL-17A receptor deficient mice
were not protected against pneumococcal disease in contrast to mice lacking in IFNγ or IL-4,
which were protected. In another study, the protective effects of Th17 cells were reinforced in
which mice depleted of either IL-17A or CD4+ T cells were not able to recruit monocytes and
macrophages which are crucial to the clearance of pneumococcus from the mucosal surface
[7]. While the role of CD4+ Th17 cells in pneumococcal diseases in animal studies is well sup-
ported, it is unclear in humans [7,8,9].
Th17 responses are regulated by regulatory T cells (Tregs) [10]. The importance of Tregs in
pneumococcal carriage was unknown until recently. One study found a significant number of
Tregs were found in adenoids from children who were positive for pneumococcus compared to
those who were negative [11]. This supports the association of pneumococcal carriage in the
nasopharynx with increased Treg activity. Other ex vivo human studies demonstrated that
Tregs possessed an inhibitory effect on pneumococcal specific CD4+ T cell proliferation which
further supports their immune-inhibitory role [12]. It is well recognised that the developmental
pathways of both Th17 and Treg cell subsets are reciprocally interconnected, and the Th17/
Treg balance plays a major role in the regulation of health and diseases [13]. During pneumo-
coccal infections, this balance is disturbed, promoting inflammation. Therefore, this may result
in an inverse association between Treg and Th17 responses in vivo.
The relationship between IL-17A levels, carriage density and the development of pneumo-
coccal disease is less understood. Given that IL-17A protects against carriage, we were interest-
ed in determining whether there was an association between IL-17A levels and carriage density
as carriage is a critical precursor for disease development.
As the density of carriage differs widely between individuals, we hypothesized that children
with stronger Th17 responses may have lower pneumococcal carriage density. In this study, we
examined the Th17 (IL-17A, IL-21, IL-22), Treg (IL-10, TGF-β) and other pro-inflammatory
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(TNF-α, IL-6, IFN-γ) cytokine profile secreted by peripheral blood mononuclear cells
(PBMCs) from Fijian children with high and low densities of nasopharyngeal pneumococcal
carriage. We found that elevated levels of Th17 secreted cytokines are associated with children
with low pneumococcal carriage, supporting and extending previous murine studies demon-
strating the protective roles of IL-17A and Th17-related cytokines against pneumococcal
colonisation.
Material and Methods
Study population and design
Samples used in this study were from healthy children (N = 65) aged 5–7 years old who were
previously vaccinated with various pneumococcal vaccine schedules as part of the Fiji Pneumo-
coccal Project (FiPP) [14] and who had detectable nasopharyngeal carriage density measured
by qPCR. We also randomly selected 29 children from this study who did not carry pneumo-
coccus as our control group. The demographics of these children are shown in S1 Table. A fol-
low up study was undertaken to assess long term immune protection in these children. Written
informed consent was obtained from the parents/guardians of study participants. Blood and
nasopharyngeal swabs were collected from each child. The study was approved by the Fiji Na-
tional Research Ethics Review Committee and the Royal Children’s Hospital Human Research
Ethics Committee. The study was conducted and monitored according to Good Clinical
Practice.
Measurement of carriage
Nasopharyngeal swabs were collected, transported, stored, and processed in line with the
World Health Organization guidelines [15,16]. Swabs were placed in 1 mL of Skim Milk tryp-
tone-glycerol-glucose (STGG) medium and stored at -80°C until use. Genomic DNAwas ex-
tracted from a 100 μl aliquot of sample using the QIAmp DNA minikit (Qiagen) as previously
described [17]. S. pneumoniae density was examined using quantitative real-time PCR (qPCR)
targeting the lytA gene using previously published primers and probes [18].
Blood collection and peripheral blood mononuclear cells (PBMCs)
culture
Peripheral blood was collected from participants and PBMCs isolated by Ficoll density gradient
centrifugation. Ex vivo PBMCs were re-suspended in RPMI-FCS at a density of 2x106 cells/mL
and 100 μL/ well seeded in 96 well round bottom plate, then stimulated with an antigenic cock-
tail containing pokeweed mitogen (83ng/mL), CpG (1.7μg/mL) and S. aureus Cowan strain for
6 days at 37°C with 5% CO2 and 95% humidity. After incubation, supernatants were collected
and frozen at -80°C until being assayed for cytokines.
Measurement of cytokines
Levels of IL-17A, TNF-α, IFN-γ, IL-10 and IL-6 in PBMC supernatants were measured using a
multiplex bead array method (Biorad, Hercules, USA). Commercial ELISA kits were used to
detect IL-21, IL-22, IL-23 (ebioscience, San Diego, USA) and TGF-β (R&D systems, Minneapo-
lis, USA).
Statistics
Comparison of carriage density between high and low carriage groups was performed using
the Mann-Whitney U test. Cytokine levels between the two carriage groups were compared
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using the Student’s t test. Cytokines concentrations were log (base e) transformed due to non-
normal distribution of the data. The Spearman test was used to determine the correlation be-
tween the Th17 cytokines and carriage density. A p<0.05 was considered statistically signifi-
cant in all cases. Analyses were performed using GraphPad Prism version 5 software package.
Results
Relationship between pneumococcal carriage density and IL-17A
cytokine levels
To determine the role of IL-17A, we separated children (N = 65) into those with the highest
(N = 27) and lowest (N = 27) pneumococcal carriage densities, resulted in defining our thresh-
olds as>8.21x105 CFU/ml (‘high’ carriage density) and<1.67x105 CFU/ml (‘low’ carriage
density). Children with mid-level colonisation were excluded for this analysis (N = 11). There
was a significant difference in carriage density between these two groups (p<0.0001; Fig 1A).
There was a significant 2.4-fold higher IL-17A level in the low carriage density group (303.3
±62.1 pg/ml) compared with the high carriage density group (126±18.2 pg/ml; p = 0.002; Fig
1B). There were also significantly higher IL-17A levels in the low carriage group in comparison
with children who did not carry pneumococci (p = 0.002; Fig 1B). No difference in IL-17A lev-
els were observed between children in the high and no carriage groups (Fig 1B).
Based on this difference in IL-17A levels between these two groups, we next examined
whether there was a correlation between IL-17A levels and pneumococcal carriage density for
all children. There was a significant inverse correlation between pneumococcal carriage density
and IL-17A levels (N = 65; r = -0.32, p = 0.008; Fig 2A). However, there was a significant corre-
lation between IL-17A levels in children with low pneumococcal carriage density (r = 0.40,
p = 0.04; Fig 2B) but not in children with high pneumococcal carriage density (r = -0.07,
p = 0.714; Fig 2C).
Cytokine profile in children with low and high pneumococcal carriage
densities
We examined the Th17 cytokine profile from children in Fiji with high (N = 27) and low
(N = 27) pneumococcal carriage. There was a significant difference for IL-23 (1.5-fold,
p = 0.04) while IL-22 was borderline significant (1.5-fold, p = 0.057) between the two carriage
groups (Fig 3B). IL-21 was not detected (data not shown). No difference in the levels of other
pro-inflammatory or Treg cytokines such as IFN-γ, IL-6, TNF-α, IL-10 and TGF-β between
the two carriage groups were found (Fig 3C and 3D). Measurement of plasma cytokine levels
did not reveal any detectable response (data not shown).
Consistent with this, significantly higher Th17/Treg cytokine ratios in children with low
pneumococcal carriage compared to children with high pneumococcal carriage were observed,
with a fold change of 1.9 for IL-17/IL-10 (p = 0.018) and 1.5 for IL-17/TGF-β (p = 0.031)
(Fig 4).
There was a close to significant positive correlation between IL-17A and IL-22 (r = 0.28,
p = 0.059) (Fig 5A), while no correlation was observed between IL-17A and IL-23 levels (Fig 5B).
Discussion
To our knowledge, this study is the first to characterise the relationship between Th17 re-
sponses and pneumococcal carriage density in children aged 5 to 7 years. We demonstrated
that low pneumococcal carriage density was associated with increased IL-17A secretion in chil-
dren. Prior studies have been in mouse models of pneumococcal colonisation and
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demonstrated a protective role for IL-17A against pneumococcal carriage [7,8,19]. Our find-
ings add support to the emerging role of IL-17A in protecting against pneumococcal colonisa-
tion. As pneumococcal colonisation is a pre-requisite for the development of IPD, strategies
that effectively target Th17 responses may be of significant benefit in reducing pneumococcal
carriage in children at greatest risk of pneumococcal disease.
Fig 1. IL-17A levels in children with high and low pneumococcal carriage densities. (A) Carriage
density >8.21 x 105 CFU/ml was defined as a ‘high’ carrier and <1.67 x 105 CFU/ml was defined as a ‘low’
carrier. Scatter plots show the median ± interquartile range for children with high carriage (N = 27) and low
carriage (N = 27). Statistical comparisons were done using Mann-Whitney U test. (B) IL-17A levels in PBMC
supernatants from children in Fiji with high (N = 27) or low (N = 27) pneumococcal carriage densities as well
as children that did not carry pneumococcus (N = 29). Bars represent mean ± SEM. Statistical comparisons
were done using an unpaired Student’s t test.
doi:10.1371/journal.pone.0129199.g001
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A number of studies have shown that CD4+ Th17 cells protect against pneumococcal car-
riage [9,19,20]. This role for IL-17A was reinforced by our data demonstrating higher IL-17A
and other Th17-related cytokines (IL-22 and IL-23) in children with low pneumococcal car-
riage density compared to those with high carriage density. IL-17A is a signature cytokine pro-
duced by CD4+ Th17 cells and IL-21 and IL-22 are other cytokines produced by this subset
[21,22]. In the context of pneumococcal diseases, IL-22 can induce production of anti-microbial
peptides such as beta defensin 2 which can inhibit the growth of the pneumococcus, and is also
important for protection against different infections including pneumonia caused by Gram-
negative bacteria [23,24]. IL-23, although strictly not part of the Th17 pathway, promotes the
development, proliferation and maintenance of Th17 cells [25]. Furthermore, Th17 and Treg
cells are known to be reciprocally regulated during inflammation. Our data showed no differ-
ence in the Treg cytokines, IL-10 and TGF-β, between children with high or low pneumococcal
carriage density. In addition, the higher Th17/Treg ratios associated with low density
Fig 2. Relationship between pneumococcal carriage densities and IL-17A levels (A) Pneumococcal nasopharyngeal (NP) carriage densities in all
65 children from Fiji wasmeasured by qPCR. IL-17A was measured by multiplex bead array. One child was removed from the analysis as an outlier
(Carriage density = 1.65x105 CFU/ml, IL-17A = 1710pg/ml). The correlation with the outlier was R = -0.19, p = 0.126. Correlation between IL-17A and children
with low pneumococcal carriage density (B; N = 27) or children with high pneumococcal carriage density (C; N = 27). The Spearman test was used to
correlate children with pneumococcal carriage density and IL-17A levels.
doi:10.1371/journal.pone.0129199.g002
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Fig 3. Cytokine profiles in PBMCs from children with low and high pneumococcal carriage densities. (A) Relationship between Th17 and Tregs under
normal immune homeostasis and under different diseases contexts (Figure taken from [36]). Th17 cells are the major source of IL-17A which plays a
protective role against pneumococcal infection, fungal infection and extracellular bacteria such as Staphylococcus aureus. However, in autoimmune and
chronic inflammatory diseases such as Multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease and psoriasis, IL-17A is known to be pathogenic
(Adapted from [12,37,38]). Comparison of (B) IL-23 and IL-22 (Th17) (C) TGF-β and IL-10 (Tregs) (D) IL-6, IFN-γ and TNF-α (pro-inflammatory cytokines)
levels between children with high or low pneumococcal carriage densities. Bars represent mean ± SEM. Statistical comparisons were done using an
unpaired Student’s t test.
doi:10.1371/journal.pone.0129199.g003
Association of Il-17A Levels and Pneumococcal Nasopharyngeal Carriage
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pneumococcal carriage further suggests an overall skewing towards the Th17 phenotype in
these children.
Interestingly, we found a strong correlation between IL-17A and low pneumococcal carriage
density but not with high pneumococcal carriage density. It is possible under conditions of low
pneumococcal carriage density, IL-17A may be important in controlling the inflammatory pro-
cess thereby limiting the spread of pneumococcus in the nasopharynx. In contrast, IL-17A re-
sponses may be less able to control pneumococcal carriage under high density conditions.
Alternatively, dysregulated or ineffective IL-17A responses may provide a conducive environ-
ment to allow the pneumococcus to survive in greater numbers. Paradoxically, IL-17A levels
were lower in children that did not carry pneumococcus compared with children with low
pneumococcal carriage density. While it may be anticipated that these children would have
higher IL-17A levels, this could be explained by the fact that IL-17A levels in these children
may be due to inflammatory responses not related to the pneumococcus. Children at this age
Fig 4. Th17/Treg balance is different in children with low and high pneumococcal carriage densities. The Th17/Treg axis is shown for IL-17A/IL-10 (A)
and IL-17A/TGF-β (B) Bars represent mean ± SEM. Comparisons were done using an unpaired Student’s test.
doi:10.1371/journal.pone.0129199.g004
Fig 5. Correlation between IL-17A and other Th17 cytokines IL-22 (A) and IL-23 (B) levels in PBMCs from children with high and low pneumococcal
carriage density (N = 46). The Spearman test was used to correlate the cytokine levels.
doi:10.1371/journal.pone.0129199.g005
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are known to carry other organisms in the nasopharynx such asHaemophilus influenzae,
Staphylococcus aureus as well as a number of viruses [17,26,27]. Additionally, other factors
such as exposure to the organism may be more important in determining whether colonisation
occurs, whereas IL-17A may be involved in limiting colonisation density.
While the carriage thresholds used in this study demonstrated a difference in IL-17A levels,
there is a lack of consensus on the definition of high or low carriage density. High pneumococ-
cal load has been associated with disease severity, with one study showing a pneumococcal load
above 105 CFU/ml in serum was associated with increased mortality [28]. Another study
showed that higher nasopharyngeal pneumococcal load was detected in Vietnamese children
with radiologically confirmed pneumonia compared with healthy controls and children with
lower respiratory tract infections [29]. Similarly, other studies have reported a correlation be-
tween nasopharyngeal pneumococcal load and disease severity disease, although IL-17A levels
were either not measured or associated with respiratory disease outcomes [30,31,32]. The
thresholds defined in this study were based on correlating pneumococcal carriage with IL-17A
levels and supports a role for IL-17A in low pneumococcal carriage density. However, further
studies in larger cohorts are needed to confirm this relationship. Determination of optimal car-
riage thresholds is dependent on a number of factors such as bacterial species, type of specimen
collected, patient cohort, the disease setting and socio-economic status. Using a threshold of
1x106 CFU/ml did not reveal any differences in IL-17A levels (data not shown), and found that
adjusting this threshold and excluding some participants with mid-level colonisation was more
useful to examine the role of IL-17A in pneumococcal colonisation. In addition, there was a
significant difference in IL-17A levels when we examined the thresholds>106 CFU/ml, N = 25
(high pneumococcal carriage density) and<105 CFU/ml, N = 19 (low pneumococcal carriage
density) (data not shown). While this gives us confidence, further studies in larger cohorts are
needed to confirm the validity of these thresholds.
In Fiji, ethnicity has an impact on carriage of pneumococci and other bacterial species. The
population of Fiji consists of 57% indigenous Fijians (known as i-Taukei) and 38% Indo-Fijians
(of Indian descent), with iTaukei Fijians having higher rates of pneumococcal carriage [14,17].
In our study, the two carriage groups contained children that were predominantly iTaukei
(85% and 96% for low and high carriage groups, respectively), suggesting that the differences
in carriage densities were not attributed to ethnicity alone. As expected, the no carriage group
had a higher proportion of Indo-Fijians and a lower proportion of iTaukei Fijians compared to
other carriage groups. Furthermore, the differences in carriage density were not related to
PCV7 or pneumococcal polysaccharide vaccine use as children in both groups had a similar
vaccination history. Based on this, it is likely other biological factors between children in these
groups such as immune function, host pathogen interactions, and exposure to pneumococcus
may have contributed to the differences in carriage density observed. Here, we report that dif-
ferences in IL-17A levels relate to colonization density, although other factors may be involved.
It would be interesting to examine the relationship between pneumococcal serotypes, coloniza-
tion density, and IL-17A, but a large sample size would be required for serotype-specific analy-
ses. Likewise, a longitudinal study design would be needed to investigate the relationship of
colonization and IL-17A over time.
Lundgren and co-workers were the first to characterise and compare Th17 responses in chil-
dren and adults from a developed country (Sweden) and developing country (Bangladesh) [5].
However, pneumococcal carriage densities were not examined and so data could only be com-
pared betweens populations with high and low pneumococcal exposure. These ex vivo human
studies showed IL-17A is produced primarily by the CD4+ memory T cells, but not CD4
+ naïve T cells, in response to pneumococcal whole cell antigen stimulation. The same study
also found higher levels of IL-17A and a greater proportion of CD4+ memory T cells in
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children from Bangladesh than children from Sweden. The higher IL-17A levels in Bangladeshi
children is possibly explained by a higher proportion of CD4+ memory T cells in this high risk
population due to frequent infections during early life. Therefore, IL-17 secreting CD4+ memo-
ry T cells are important for protection and a potential marker or correlate of protection after
exposure to pneumococci. In our study, we were unable to do these analyses due to lack of
cells. IL-17 is produced by numerous cell populations including CD4+ Th17 cells, NK cells, γδ
T cells, CD8+ T cells and innate lymphoid cells [33]. However, a recent study demonstrated B
cells also secrete IL-17 during infection with the protozoan parasite Trypanosoma cruzi and
confer protection against this parasitic infection [34]. In our study, the source of IL-17 was
PBMCs, predominately a lymphocyte population.
The role of Th17 in mediating immunity against pneumococcal colonisation and disease is
of significant interest, has led to the development of a killed whole cell pneumococcal vaccine
(WCV). A recent study found that WCV conferred protection in mouse models of carriage by
reducing colonisation in a CD4+ T cell, IL-17A mediated mechanism [8]. The WCV could be
an alternative approach to current PCVs as this vaccine is based on an unencapsulated strain
of pneumococcus containing multiple proteins such as PspA conserved across the majority of
serotypes, and may potentially prevent or reduce serotype replacement [14,35]. Ongoing stud-
ies in populations at high risk of disease such as Indonesia and Kenya to evaluate the WCV
immunogenicity and impact on carriage are a priority.
Several limitations of our study need to be addressed. Firstly, this study was conducted in a
relatively small number of children and our results need to be confirmed in larger studies. Sec-
ondly, due to the small sample size, differences in cytokine responses between ethnicities (i-
Taukei versus Indo-Fijians) could not be determined. As the majority of the children in this co-
hort are i-Taukei, the results will need to be confirmed in other ethnic groups or settings. Last-
ly, our Th17 cytokine responses were measured in PBMC supernatants rather than the
mucosal compartment, which would better reflect the local inflammatory response in the naso-
pharynx and may correlate better with carriage density data. However, direct measurement of
Th17 responses in the nasopharynx is more challenging, particularly in human studies. Overall,
there is a need for future clinical studies that examine the role of Th17 immunity in pneumo-
coccal carriage and disease.
Conclusion
Our results add to the emerging role for Th17 mediated protection against pneumococcal colo-
nisation: Higher IL-17A levels were associated with lower carriage density. Therefore, CD4
+ Th17, IL-17 secreting B cells and Th17 family of cytokines may be important biomarkers in
predicting long term protection against pneumococcal carriage. Our data in humans also sup-
ports the potential benefits of vaccine strategies that stimulate IL-17A-based protection such as
WCV.
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